UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Your skills can be a valuable source of income. Explore ways to use skills for extra income and maximize your earning potential.
20,974 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
All 50 states now report average gas prices above $4 per gallon as the summer driving season begins. Analysts warn pr...
A new northwestern mutual 2025 study exposes a sharp mismatch: Millennials prize wealth transfer yet most have not se...
Retail investors push Ford into meme-stock territory as Wall Street holds, sparking a heated debate about the automak...
Mortgage demand dropped sharply in the latest MBA survey, with refinances leading the decline as rates trended higher...
April inflation rose to 3.8% year over year, the hottest in nearly three years, as gas and groceries push costs highe...
Regulators are tightening control over cash-to-crypto channels as Bitcoin ATMs—the devices that brought crypto into e...
A top AI analyst argues the AI revolution is still in its early stages, with ASML’s hefty backlog and robust Q1 2026 ...
Solar’s most hated year is fading into a powerful five-month rally. The Invesco SOLAR ETF has surged roughly 45% sinc...
STRC dips to about $94.65, roughly 5% under its $100 par, renewing questions about Strategy's bitcoin strategy and th...
A fresh volley of missiles from Iran toward Israel marks a dangerous escalation that unsettles global markets. With a...
May data show mortgage credit availability edges higher, led by a small loosening in jumbo loan programs despite high...